Indication
Systemic mastocytosis with associated hematologic neoplasm (SM-AHN)
1 clinical trial
1 product
Product
bezuclastinibClinical trial
A Phase 2 Open-Label, Multicenter Clinical Study of the Safety, Efficacy, Pharmacokinetic, and Pharmacodynamic Profiles of CGT9486 as a Single Agent in Patients With Advanced Systemic MastocytosisStatus: Recruiting, Estimated PCD: 2025-01-01